Accéder au contenu principal

Sélection

Humble Choice July 2024 Bundle Includes A Plague Tale, Ghostrunner 2, Starship Troopers, And More

Humble Choice July 2024 Bundle Includes A Plague Tale, Ghostrunner 2, Starship Troopers, And More https://ift.tt/R5aXVYM Another month has dawned, and that means Humble has another bundle of PC games available for its Humble Choice subscribers ($12/month). This month, there are eight games available in the bundle, including some big-name indie sequels like A Plague Tale: Requiem and Ghostrunner 2, plus a selection of shooters, strategy games, and action games, all of which are yours to keep forever, even if you cancel your Humble Choice subscription. On top of the games, this month's bundle also includes a surprising bonus: a month of DC Universe Infinite, which lets you read thousands of DC Comics in the DC Universe app. Sign up for Humble Choice Humble Choice July 2024 games Ghostrunner 2 A Plague Tale: Requiem Starship Troopers: Terran Command Sticky Business Zoeti Figment 2: Creed Valley Heretic's Fork Hyperviolent Bonus: One-month subscription to DC Universe In

Dune 2 Could Be Delayed Due To Ongoing Strikes

Dune 2 Could Be Delayed Due To Ongoing Strikes https://ift.tt/duKwEci

The upcoming Dune sequel set for release later this year might slip to 2024 due to the ongoing writer and actor strikes. According to Variety, Warner Bros. is "strongly considering" pushing Dune 2 to next year.

The movie is currently slated to release on November 3, and Warner Bros. has not officially shifted it yet. But three sources told Variety that the movie company is considering delaying the film. Warner Bros. and Legendary Entertainment are producing the movie together, and both parties need to agree to a delay and a new date, the report said. A different source said Dune 2 is still on track for November.

Sources also told Variety that some of WB's other upcoming films, including Aquaman and The Lost Kingdom and The Color Purple, may be delayed due to the strikes.

Continue Reading at GameSpot

Commentaires

Articles les plus consultés